⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL708271 | 1.00 | — | — | |
| SCHEMBL51793 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL51792 | 0.98 | CYP3A4 (0.44) | — | |
| Methane SCHEMBL28919172 | 0.98 | CYP3A4 (0.44) | — | |
| Hydrochloric Acid SCHEMBL27762272 | 0.98 | CYP3A4 (0.44) | — | |
| Hydrochloric Acid SCHEMBL190501 | 0.98 | CYP3A4 (0.44) | — | |
| Hydrochloric Acid SCHEMBL1223341 | 0.98 | CYP3A4 (0.44) | — | |
| Water SCHEMBL16400402 | 0.98 | CYP3A4 (0.44) | — | |
| Ammonia Solution, Strong SCHEMBL16464378 | 0.98 | CYP3A4 (0.44) | — | |
| SCHEMBL2237837 | 0.98 | CYP3A4 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2443 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119470406-A | Phthalic dicarboxaldehyde disinfectant concentration detection test paper and preparation method thereof | 山东新华莎罗雅生物技术有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-118324679-A | All-natural framework molecular compound, preparation method thereof and application thereof in electrolyte micro-region mechanical stress measurement | 江西广源化工有限责任公司 | 2024-07-12 | — | — | CN | claimed |
| CN-115611964-B | Ursolic acid saponin with inflammatory bowel disease treatment effect, derivative thereof, preparation method and application | 沈阳药科大学 | 2024-02-06 | — | — | CN | claimed |
| EP-3886990-B1 | NOVEL L-PROLINE SULFONAMIDE DERIVATIVES COMPRISING PYRAZOLO[4,3- E]TETRAZOLO[4,5-B][1,2,4]TRIAZINE SYSTEM, METHOD OF MANUFACTURING THEREOF, USES THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | UNIV MEDYCZNY W BIALYMSTOKU (PL) | 2023-06-07 | — | — | EP | claimed |
| CN-115583871-B | All C 13 Preparation method of isotope labeled decabromodiphenyl ether | 烟台大学 | 2023-05-12 | — | — | CN | claimed |
| CN-116003462-A | Silicon-based substituted chiral amine and preparation method and application thereof | 南开大学 | 2023-04-25 | — | — | CN | claimed |
| CN-111410812-B | Preparation method of spiral polyphenylacetylene/silicon-based hybrid porous material | 哈尔滨工程大学 | 2023-03-21 | — | — | CN | claimed |
| CN-115611964-A | Ursolic acid saponin with inflammatory bowel disease treatment effect, derivatives thereof, preparation method and application | 沈阳药科大学 | 2023-01-17 | — | — | CN | claimed |
| CN-115583871-A | Full C 13 Preparation method of isotope-labeled decabromodiphenyl ether | 烟台大学 | 2023-01-10 | — | — | CN | claimed |
| CN-112675920-B | Mono-chiral center catalyst, preparation thereof and method for catalytically synthesizing chiral alcohol compound and chiral alpha-allyl alcohol | 南方科技大学 | 2022-12-20 | — | — | CN | claimed |
| EP-1450791-A1 | HYDRAZONOPYRAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTICS | Kinetek Pharmaceuticals, Inc. (CA) | 2004-09-01 | — | — | EP | claimed |
| US-6723856-B1 | DISSOLVING PROLINE IN DRY ALCOHOL, COOLING TO -5 C. TO -15 C., THIONYLCHLORIDE, ALKALI CARBONATE, DISTILLING, DISSOLVING THE 2-CARBOMETHOXY-1-PYRROLIDINE IN ETHER, METHYLMAGNESIUM IODIDE GRIGNARD | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2004-04-20 | — | — | US | claimed |
| WO-2003080610-A1 | IMIDAZOPYRIDINE DERIVATIVES AS KINASE INHIBITORS | GLAXO GROUP LIMITED (GB) | 2003-10-02 | — | — | WO | claimed |
| WO-2003045379-A1 | HYDRAZONOPYRAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTICS | KINETEK PHARMACEUTICALS, INC. (CA) | 2003-06-05 | — | — | WO | claimed |
| EP-1276730-A2 | THIAZOLIDINEDIONE ANALOGUES AND THEIR USE FOR THE TREATMENT OF DIABETES | ARYx Therapeutics (US) | 2003-01-22 | — | — | EP | claimed |
| WO-2001081328-A2 | THIAZOLIDINEDIONE ANALOGUES AND THEIR USE FOR THE TREATMENT OF DIABETES | ARYX THERAPEUTICS (US) | 2001-11-01 | — | — | WO | claimed |
| US-5102882-A | Nootropic agents | NIPPON SHINYAKU CO., LTD. (JP) | 1992-04-07 | — | — | US | claimed |
| CN-86105870-A | Band 5-amino-2, the blood vessel tension peptide protoenzyme inhibitor of 5-two replacement-4-hydroxypentanoic acid bases | — | 1987-03-11 | — | — | CN | claimed |
| EP-0212903-A2 | Polypeptide derivatives containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues | PFIZER INC. (US) | 1987-03-04 | — | — | EP | claimed |
| US-4157435-A | TITANIUM, ALUMINUM, SILOXANE COORDINATION CATALYST | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1979-06-05 | — | — | US | claimed |